Is wider surgical margin justified for better clinical outcomes in patients with resectable hepatocellular carcinoma?

Journal of the Formosan Medical Association

Volumn 111, Issue 3, 2012, Pages 160-170

  Lee, King Teh ^a,b   Wang, Shen Nien ^a   Su, Rong Wei ^b   Chen, Hong Yaw ^c   Shi, Hon Yi ^b   Ker, Chen Go ^a   Chiu, Herng Chia ^b  

^a KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^c Yuan's Hospital   (Taiwan)

Author keywords

Clinical outcome; Hepatocellular carcinoma; Surgical margin

Indexed keywords

ARTICLE; BLOOD TRANSFUSION; CANCER RECURRENCE; CANCER SURGERY; CANCER SURVIVAL; CLINICAL FEATURE; DISEASE FREE SURVIVAL; FOLLOW UP; HUMAN; LIVER CELL CARCINOMA; LIVER RESECTION; MAJOR CLINICAL STUDY; MEDICAL PARAMETERS; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PERIOPERATIVE PERIOD; POSTOPERATIVE COMPLICATION; POSTOPERATIVE PERIOD; RECURRENCE RISK; RETROSPECTIVE STUDY; SURGICAL MARGIN; SURGICAL MORTALITY;

AGED; CARCINOMA, HEPATOCELLULAR; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; KAPLAN-MEIER ESTIMATE; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PROPORTIONAL HAZARDS MODELS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84862826300     PISSN: None     EISSN: 09296646     Source Type: Journal    
DOI: 10.1016/j.jfma.2011.02.002     Document Type: Article

References (40)

1. Yeh C.N., Chen M.F., Lee W.C., Jeng L.B. Prognostic factors of hepatic resection for hepatocellular carcinoma with cirrhosis: univariate and multivariate analysis. J Surg Oncol 2002, 81:185-202.
2. Lee K.T., Lu Y.W., Wang S.N., Chen H.Y., Chuang S.C., Chang W.T., et al. The effect of preoperative transarterial chemoembolization of resectable hepatocellular carcinoma on clinical and economic outcomes. J Surg Oncol 2009, 99:343-350.
3. Shi M., Guo R.P., Lin X.J., Zhang Y.Q., Chen M.S., Zhang C.Q., et al. Partial hepatectomy with wide versus narrow resection margin for solitary hepatocellular carcinoma: a prospective randomized trial. Ann Surg 2007, 245:36-43.
4. Zhou X.P., Quan Z.W., Cong W.M., Yang N., Zhang H.B., Zhang S.H., et al. Micrometastasis in surrounding liver and the minimal length of resection margin of primary liver cancer. World J Gastroenterol 2007, 13:4498-4503.
5. Regimbeau J.M., Kiammanesh R., Farges O., Dondero F., Sauvanet A., Belghiti J. Extent of liver resection influences the outcome in patients with cirrhosis and small hepatocellular carcinoma. Surgery 2002, 131:311-317.
6. Matsue Y., Terakawa N., Satoi S., Kaibori M., Kitade H., Takai S., et al. Postoperative outcomes in patients with hepatocellular carcinoma resected with exposure of the tumor surface. Arch Surg 2007, 142:596-602.
7. Poon R., Fan S.T., Ng I., Wong J. Significance of resection margin in hepatectomy for hepatocellular carcinoma. Ann Surg 2000, 231:544-551.
8. Yamashita Y.I., Takeromi A., Itoh S., Kitagawa D., Kayashima H., Harimoto N., et al. Long-term favorable results of limited hepatic resections for patients with hepatocellular carcinoma: 20 years of experience. J Am Coll Surg 2007, 205:19-26.
9. Wu J.C., Huang Y.H., Chau G.Y., Su C.W., Lai C.R., Lee P.C., et al. Risk factors for early and late recurrence in hepatitis B-related hepatocellular carcinoma. J Hepatol 2009, 51:890-897.
10. Poon R., Fan S.T., Wong J. Risk factors, prevention, and management of postoperative recurrence after resection of hepatocellular carcinoma. Ann Surg 2000, 232:10-24.
11. Chiu J.H., Kao H.L., Wu L.H. Prediction of relapse or survival after resection in human hepatoma by DNA flow cytometry. J Clin Invest 1992, 89:539-545.
12. Suehiro T., Matsumata T., Itasaka H. Clinicopathologic features and prognosis of resected hepatocellular carcinoma of various sizes with special reference to proliferating cell nuclear antigen. Cancer 1995, 76:399-405.
13. Suda T., Isokawa O., Aoyagi Y. Quantitation of telomerase acting in hepatocellular carcinoma: a possible aid for a prediction of recurrent disease in the remnant liver. Hepatology 1998, 27:402-406.
14. Boix L., Castells A., Bruix J. Androgen receptors in hepatocellular carcinoma and surrounding liver: relationship with tumor size and recurrence rate after surgical resection. J Hepatol 1995, 22:616-622.
15. Ng I.O.L., Lai E.C.S., Chan A.S., So M.K.P. Overexpression of p53 in hepatocellular carcinoma: a clinicopathological and prognosis correlation. J Gastroenterol Hepatol 1995, 10:250-255.
16. Mise M., Arii S., Higashituji H. Clinical significance of vascular endothelial growth factor and basic fibroblast growth factor gene expression in liver tumor. Hepatology 1996, 23:455-464.
17. Hamatsu T., Rikimaru T., Yamashita Y., Aishima S., Tanaka S., Shirabe K., et al. The role of MTA1 gene expression in human hepatocellular carcinoma. Oncol Rep 2003, 10:599-604.
18. Ryu S.H., Chung Y.H., Lee H., Kim J.A., Shin H.D., Min H.J., et al. Metastatic tumor antigen 1 is closely associated with frequent postoperative recurrence and poor survival in patients with hepatocellular carcinoma. Hepatology 2008, 47:929-936.
19. Budhu A., Jia H.L., Forgues M., Liu C.G., Goldstein D., Lam A., et al. Identification of metastasis-related microRNAs in hepatocellular carcinoma. Hepatology 2008, 47:897-907.
20. Li W., Xie L., He X., Li J., Tu K., Wei L., et al. Diagnostic and prognostic implications of microRNAs in human hepatocellular carcinoma. Int J Cancer 2008, 123:616-622.
21. Okamura D., Ohtsuka M., Kimura F., Shimizu H., Yoshidome H., Kato A., et al. Ezrin expression is associated with hepatocellular carcinoma possibly derived from progenitor cells and early recurrence after surgical resection. Mod Pathol 2008, 21:847-855.
22. Nakanishi K., Sakamoto M., Yamasaki S., Todo S., Hirohashi S. Akt phosphorylation is a risk factor for early disease recurrence and poor prognosis in hepatocellular carcinoma. Cancer 2005, 103:307-312.
23. Fu J., Xu D., Liu Z., Shi M., Zhao P., Fu B., et al. Increased regulatory T cells correlate with CD8 T-cell impairment and poor survival in hepatocellular carcinoma patients. Gastroenterology 2007, 132:2328-2339.
24. Chuma M., Hige S., Kamiyama T., Meguro T., Nagasaka A., Nakanishi K., et al. The influence of hepatitis B DNA level and antiviral therapy on recurrence after initial curative treatment in patients with hepatocellular carcinoma. J Gastroenterol 2009, 44:991-999.
25. Uenishi T., Nishiguchi S., Tamori A., Yamamoto T., Shuto T., Hirohashi K., et al. Influence of interferon therapy on outcome after surgery for hepatitis C virus-related hepatocellular carcinoma. Hepatol Res 2006, 36:185-200.
26. Toshifumi W., Yoshio S., Jun S., Kaneko K., Cruz P.V., Akazawa K., et al. Anatomic resection independently improves long-term survival in patients with T1-T2 hepatocellular carcinoma. Ann Surg Oncol 2007, 14:1356-1365.
27. Shinchi U., Fumitake K., Masahiko S., Hiwatashi K., Tateno T., Mataki Y., et al. Efficacy of anatomic resection vs. nonanatomic resection for small nodular hepatocellular carcinoma based on gross classification. J Hepatobiliary Pancreat Surg 2008, 15:493-500.
28. Kaibori M., Matsui Y., Hijikawa T., Uchida Y., Kwon A.H., Kamiyama Y. Comparison of limited and anatomic hepatic resection for hepatocellular carcinoma with hepatitis C. Surgery 2006, 139:385-394.
29. Kuniya T., Hiroshi S., Chizuru M., Matsuo K., Nagano Y., Endo I., et al. Anatomic versus limited nonanatomic resection for solitary hepatocellular carcinoma. Surgery 2008, 143:607-615.
30. Shiba H., Ishida Y., Wakiyama S., lida T., Matsumoto M., Sakamoto T., et al. Negative impact of blood transfusion on recurrence and prognosis of hepatocellular carcinoma after hepatic resection. J Gastrointest Surg 2009, 13:1636-1642.
31. Tralhao J.G., Kayal S., Dagher I., Sanhueza M., Vons C., Franco D. Resection of hepatocellular carcinoma: the effect of surgical margin and blood transfusion on long-term survival. Analysis of 209 consecutive patients. Hepatogastroenterology 2007, 54:1200-1206.
32. Dahiya D., Wu T.J., Lee C.F., Chan K.M., Lee W.C., Chen M.F. Minor versus major hepatic resection for small hepatocellular carcinoma (HCC) in cirrhotic patients: a 20-year experience. Surgery 2010, 147:676-685.
33. Laurent C., Blanc J.F., Nobili S., Sa Cunha A., le Bail B., Bioulac-Sage P., et al. Prognostic factors and long-term survival after hepatic resection for hepatocellular carcinoma originating from noncirrhotic liver. J Am Coll Surg 2005, 201:656-662.
34. Katz S.C., Shia J., Liau K.H., Gonen M., Ruo L., Jarnagin W.R., et al. Operative blood loss independently predicts recurrence and survival after resection of hepatocellular carcinoma. Ann Surg 2009, 249:617-623.
35. Chok K.S., Ng K.K., Poon R.T., Lo C.M., Fan S.T. Impact of postoperative complications on long-term outcome of curative resection for hepatocellular carcinoma. Br J Surg 2009, 96:81-87.
36. Schiffiman S.C., Woodall C.E., Kooby D.A., Martin R.C., Staley C.A., Egnatashvili V., et al. Factors associated with recurrence and survival following hepatectomy for large hepatocellular carcinoma: a multicenter analysis. J Surg Oncol 2010, 101:105-110.
37. Kaibori M., Ishizaki M., Saito T., Matsui K., Kwon A.H., Kamiyama Y. Risk factors and outcome of early recurrence after resection of small hepatocellular carcinoma. Am J Surg 2009, 198:39-45.
38. Shah S.A., Greig P.D., Gallinger S., Cattral M.S., Dixon E., Kim R.D., et al. Factor associated with early recurrence after resection for hepatocellular carcinoma and outcomes. J Am Coll Surg 2006, 202:275-283.
39. Shah S.A., Cleary S.P., Wei A.C., Yang I., Taylor B.R., Hemming A.W., et al. Recurrence after liver resection for hepatocellular carcinoma: risk factors, treatment, and outcomes. Surgery 2007, 141:330-339.
40. Sumie R., Kuromatsu R., Okuda K., Ando E., Takata A., Fukushima N., et al. Microvascular invasion in patients with hepatocellular carcinoma and its predictable clinicopathological factors. Ann Surg Oncol 2008, 15:1375-1382.